Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Murine Polyomavirus Cell Surface Receptors Activate Distinct Signaling Pathways Required for Infection.

O'Hara SD, Garcea RL.

MBio. 2016 Nov 1;7(6). pii: e01836-16. doi: 10.1128/mBio.01836-16.

2.

Activation of DNA damage repair pathways by murine polyomavirus.

Heiser K, Nicholas C, Garcea RL.

Virology. 2016 Oct;497:346-356. doi: 10.1016/j.virol.2016.07.028. Epub 2016 Aug 16.

3.

WU and KI polyomavirus infections in Filipino children with lower respiratory tract disease.

Rao S, Lucero MG, Nohynek H, Tallo V, Lupisan SP, Garcea RL, Simões EAF; ARIVAC Consortium.

J Clin Virol. 2016 Sep;82:112-118. doi: 10.1016/j.jcv.2016.07.013. Epub 2016 Jul 26.

PMID:
27479174
4.

Immunizing against Anogenital Cancer: HPV Vaccines.

Pogoda CS, Roden RB, Garcea RL.

PLoS Pathog. 2016 May 19;12(5):e1005587. doi: 10.1371/journal.ppat.1005587. eCollection 2016 May. Review. No abstract available.

5.

2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment.

Patera AC, Butler SL, Cinque P, Clifford DB, Elston R, Garcea RL, Major EO, Pavlovic D, Peterson IS, Ryan AM, Tyler KL, Weber T; PML Consortium.

J Neurovirol. 2015 Dec;21(6):702-5. doi: 10.1007/s13365-015-0392-5. No abstract available.

PMID:
26501778
6.

Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus.

You J, O'Hara SD, Velupillai P, Castle S, Levery S, Garcea RL, Benjamin T.

PLoS Pathog. 2015 Oct 16;11(10):e1005175. doi: 10.1371/journal.ppat.1005175. eCollection 2015 Oct.

7.

Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity.

Buch MH, Liaci AM, O'Hara SD, Garcea RL, Neu U, Stehle T.

PLoS Pathog. 2015 Oct 16;11(10):e1005104. doi: 10.1371/journal.ppat.1005104. eCollection 2015 Oct.

8.

Development of a highly thermostable, adjuvanted human papillomavirus vaccine.

Hassett KJ, Meinerz NM, Semmelmann F, Cousins MC, Garcea RL, Randolph TW.

Eur J Pharm Biopharm. 2015 Aug;94:220-8. doi: 10.1016/j.ejpb.2015.05.009. Epub 2015 May 18.

9.

Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors.

Berrios C, Jung J, Primi B, Wang M, Pedamallu C, Duke F, Marcelus C, Cheng J, Garcea RL, Meyerson M, DeCaprio JA.

J Virol. 2015 Jan;89(1):857-62. doi: 10.1128/JVI.02328-14. Epub 2014 Oct 15.

10.

Common exposure to STL polyomavirus during childhood.

Lim ES, Meinerz NM, Primi B, Wang D, Garcea RL.

Emerg Infect Dis. 2014 Sep;20(9):1559-61. doi: 10.3201/eid2009.140561.

11.

Structure analysis of the major capsid proteins of human polyomaviruses 6 and 7 reveals an obstructed sialic acid binding site.

Ströh LJ, Neu U, Blaum BS, Buch MH, Garcea RL, Stehle T.

J Virol. 2014 Sep;88(18):10831-9. doi: 10.1128/JVI.01084-14. Epub 2014 Jul 9.

12.

Long-lasting T cell-independent IgG responses require MyD88-mediated pathways and are maintained by high levels of virus persistence.

Raval FM, Mishra R, Garcea RL, Welsh RM, Szomolanyi-Tsuda E.

MBio. 2013 Nov 5;4(6):e00812-13. doi: 10.1128/mBio.00812-13.

13.

A cornucopia of human polyomaviruses.

DeCaprio JA, Garcea RL.

Nat Rev Microbiol. 2013 Apr;11(4):264-76. doi: 10.1038/nrmicro2992. Epub 2013 Mar 11. Review.

14.

Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection.

Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, Gilbert M, Wakarchuk WW, Imamura A, Ando H, Kiso M, Arnberg N, Garcea RL, Peters T, Buck CB, Stehle T.

PLoS Pathog. 2012;8(7):e1002738. doi: 10.1371/journal.ppat.1002738. Epub 2012 Jul 26.

15.

Dynamics of urinary polyomavirus shedding in healthy adult women.

Kling CL, Wright AT, Katz SE, McClure GB, Gardner JS, Williams JT, Meinerz NM, Garcea RL, Vanchiere JA.

J Med Virol. 2012 Sep;84(9):1459-63. doi: 10.1002/jmv.23319.

16.

Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.

Bienkowska-Haba M, Williams C, Kim SM, Garcea RL, Sapp M.

J Virol. 2012 Sep;86(18):9875-87. doi: 10.1128/JVI.00980-12. Epub 2012 Jul 3.

17.

Dynamics of pregnancy-associated polyomavirus urinary excretion: a prospective longitudinal study.

McClure GB, Gardner JS, Williams JT, Copeland CM, Sylvester SK, Garcea RL, Meinerz NM, Groome LJ, Vanchiere JA.

J Med Virol. 2012 Aug;84(8):1312-22. doi: 10.1002/jmv.23320.

PMID:
22711361
18.

Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism.

Magaldi TG, Buch MH, Murata H, Erickson KD, Neu U, Garcea RL, Peden K, Stehle T, DiMaio D.

J Virol. 2012 Jul;86(13):7028-42. doi: 10.1128/JVI.00371-12. Epub 2012 Apr 18.

19.

Virion assembly factories in the nucleus of polyomavirus-infected cells.

Erickson KD, Bouchet-Marquis C, Heiser K, Szomolanyi-Tsuda E, Mishra R, Lamothe B, Hoenger A, Garcea RL.

PLoS Pathog. 2012;8(4):e1002630. doi: 10.1371/journal.ppat.1002630. Epub 2012 Apr 5.

20.

New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention.

Gersch ED, Gissmann L, Garcea RL.

Antivir Ther. 2012;17(3):425-34. doi: 10.3851/IMP1941. Epub 2011 Nov 7. Review.

Supplemental Content

Loading ...
Support Center